Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells - PubMed (original) (raw)

Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells

O Fourcade et al. Cell. 1995.

Free article

Abstract

Nonpancreatic secretory phospholipase A2 (sPLA2) displays proinflammatory properties; however, its physiological substrate is not identified. Although inactive toward intact cells, sPLA2 hydrolyzed phospholipids in membrane microvesicles shed from Ca(2+)-loaded erythrocytes as well as from platelets and from whole blood cells challenged with inflammatory stimuli. sPLA2 was stimulated upon degradation of sphingomyelin (SPH) and produced lysophosphatidic acid (LPA), which induced platelet aggregation. Finally, lysophospholipid-containing vesicles and sPLA2 were detected in inflammatory fluids in relative proportions identical to those used in vitro. We conclude that upon loss of phospholipid asymmetry, cell-derived microvesicles provide a preferential substrate for sPLA2. SPH hydrolysis, which is provoked by various cytokines, regulates sPLA2 activity, and the novel lipid mediator LPA can be generated by this pathway.

PubMed Disclaimer

Cited by

Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators.
Miki Y, Yamamoto K, Taketomi Y, Sato H, Shimo K, Kobayashi T, Ishikawa Y, Ishii T, Nakanishi H, Ikeda K, Taguchi R, Kabashima K, Arita M, Arai H, Lambeau G, Bollinger JM, Hara S, Gelb MH, Murakami M. Miki Y, et al. J Exp Med. 2013 Jun 3;210(6):1217-34. doi: 10.1084/jem.20121887. Epub 2013 May 20. J Exp Med. 2013. PMID: 23690440 Free PMC article.
C-reactive protein as a pro-inflammatory mediator in cardiovascular disease by its ability to activate complement: additional proof and hypothetical mechanisms.
Lagrand WK, Nijmeijer R, Niessen HW, Visser CA, Hermens WT, Hack CE. Lagrand WK, et al. Neth Heart J. 2002 Apr;10(4):189-197. Neth Heart J. 2002. PMID: 25696089 Free PMC article. Review.
Lipid phosphate phosphatases and their roles in mammalian physiology and pathology.
Tang X, Benesch MG, Brindley DN. Tang X, et al. J Lipid Res. 2015 Nov;56(11):2048-60. doi: 10.1194/jlr.R058362. Epub 2015 Mar 26. J Lipid Res. 2015. PMID: 25814022 Free PMC article. Review.
The role of microparticles in the pathogenesis of rheumatic diseases.
Beyer C, Pisetsky DS. Beyer C, et al. Nat Rev Rheumatol. 2010 Jan;6(1):21-9. doi: 10.1038/nrrheum.2009.229. Epub 2009 Dec 1. Nat Rev Rheumatol. 2010. PMID: 19949432 Review.
Lack of stereospecificity in lysophosphatidic acid enantiomer-induced calcium mobilization in human erythroleukemia cells.
Nilsson UK, Andersson RG, Ekeroth J, Hallin EC, Konradsson P, Lindberg J, Svensson SP. Nilsson UK, et al. Lipids. 2003 Oct;38(10):1057-64. doi: 10.1007/s11745-006-1161-2. Lipids. 2003. PMID: 14669971

Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells - PubMed (original) (raw)